GRK2
MOLECULAR TARGETG protein-coupled receptor kinase 2
GRK2 (G protein-coupled receptor kinase 2) is targeted by 10 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting GRK2
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Hesperidin | 0.69 | 1 |
| 2 | Methylene Blue | 0.69 | 1 |
| 3 | Vitamin | 0.69 | 1 |
| 4 | Aurintricarboxylic Acid | 0.69 | 1 |
| 5 | Cefixime | 0.69 | 1 |
| 6 | Flurandrenolone | 0.69 | 1 |
| 7 | Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on | 0.69 | 1 |
| 8 | streptonigrin | 0.69 | 1 |
| 9 | Terbutaline | 0.69 | 1 |
| 10 | Tetracycline | 0.69 | 1 |
About GRK2 as a Drug Target
GRK2 (G protein-coupled receptor kinase 2) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 10 compounds with documented GRK2 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
GRK2 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.